Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

NASDAQ:GLRE - Nasdaq - KYG4095J1094 - Common Stock - Currency: USD

14.44  +0.08 (+0.56%)

After market: 14.44 0 (0%)

Fundamental Rating

4

GLRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. GLRE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GLRE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year GLRE was profitable.
GLRE had a positive operating cash flow in the past year.
GLRE had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GLRE reported negative operating cash flow in multiple years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

With a Return On Assets value of 2.11%, GLRE perfoms like the industry average, outperforming 52.45% of the companies in the same industry.
GLRE has a worse Return On Equity (6.81%) than 72.03% of its industry peers.
Industry RankSector Rank
ROA 2.11%
ROE 6.81%
ROIC N/A
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Profit Margin value of 6.77%, GLRE perfoms like the industry average, outperforming 44.76% of the companies in the same industry.
GLRE's Profit Margin has improved in the last couple of years.
GLRE has a Operating Margin of 1.30%. This is amonst the worse of the industry: GLRE underperforms 81.82% of its industry peers.
GLRE's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.3%
PM (TTM) 6.77%
GM N/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GLRE has been reduced compared to 1 year ago.
GLRE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, GLRE has an improved debt to assets ratio.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

GLRE has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.58, GLRE is doing good in the industry, outperforming 76.92% of the companies in the same industry.
GLRE has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
GLRE has a better Debt to Equity ratio (0.09) than 81.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.58
Altman-Z N/A
ROIC/WACCN/A
WACC8.56%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GLRE have decreased strongly by -56.86% in the last year.
Measured over the past years, GLRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 151.28% on average per year.
GLRE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.65%.
GLRE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.32% yearly.
EPS 1Y (TTM)-56.86%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%10.26%
Revenue 1Y (TTM)2.65%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%-3.36%

3.2 Future

Based on estimates for the next years, GLRE will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.82% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-14.29%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6 -8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.19, the valuation of GLRE can be described as reasonable.
GLRE's Price/Earnings ratio is a bit cheaper when compared to the industry. GLRE is cheaper than 60.84% of the companies in the same industry.
When comparing the Price/Earnings ratio of GLRE to the average of the S&P500 Index (26.25), we can say GLRE is valued rather cheaply.
The Price/Forward Earnings ratio is 8.85, which indicates a very decent valuation of GLRE.
62.94% of the companies in the same industry are more expensive than GLRE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.15. GLRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.19
Fwd PE 8.85
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

GLRE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GLRE is more expensive than 70.63% of the companies in the same industry.
70.63% of the companies in the same industry are more expensive than GLRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.85
EV/EBITDA 58.35
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

GLRE's earnings are expected to decrease with -11.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GLRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (5/30/2025, 4:30:01 PM)

After market: 14.44 0 (0%)

14.44

+0.08 (+0.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04
Inst Owners50.48%
Inst Owner Change3.99%
Ins Owners23.98%
Ins Owner Change-0.2%
Market Cap499.05M
Analysts43.33
Price TargetN/A
Short Float %0.58%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1900.98%
Min EPS beat(2)-3870.59%
Max EPS beat(2)68.63%
EPS beat(4)2
Avg EPS beat(4)-939.86%
Min EPS beat(4)-3870.59%
Max EPS beat(4)68.63%
EPS beat(8)5
Avg EPS beat(8)-435.43%
EPS beat(12)7
Avg EPS beat(12)-367.94%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.19
Fwd PE 8.85
P/S 0.74
P/FCF 4.85
P/OCF 4.8
P/B 0.75
P/tB 0.75
EV/EBITDA 58.35
EPS(TTM)1.29
EY8.93%
EPS(NY)1.63
Fwd EY11.3%
FCF(TTM)2.98
FCFY20.61%
OCF(TTM)3.01
OCFY20.82%
SpS19.42
BVpS19.29
TBVpS19.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 6.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.3%
PM (TTM) 6.77%
GM N/A
FCFM 15.33%
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.58
Debt/EBITDA 6.86
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.81
Cash Conversion 1192.19%
Profit Quality 226.42%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.86%
EPS 3Y151.28%
EPS 5YN/A
EPS Q2Q%10.26%
EPS Next Y-14.29%
EPS Next 2Y-17.19%
EPS Next 3Y-11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)2.65%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Sales Q2Q%-3.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-88.5%
EBIT growth 3Y98.58%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y309.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y311.31%
OCF growth 3YN/A
OCF growth 5YN/A